APOE and melanoma: Melanoma patients’ apoE subtypes are found strongly associated with disease progression and efficacy of immunotherapy, which is considered as the first-time demonstration that pre-existing genes in the genome can influence malignant progression and patients’ response to immunotherapy(Ostendorf et al. 2020).